Novel markers predict HBs-antigen seroclearance in chronic hepatitis B patients from the SWAP clinical trial

被引：1

作者：

Phyo, W. W. ^{[1
]}

Cloherty, G. ^{[2
]}

Butler, E. ^{[2
]}

Kuhns, M. ^{[2
]}

Mcnamara, A. ^{[2
]}

Holzmayer, V. ^{[2
]}

Gersch, J. ^{[2
]}

Yang, W. L. ^{[3
]}

Chang, P. E. J. ^{[4
]}

Tan, J. ^{[5
]}

Taufique, A. ^{[6
]}

Dan, Y. Y. ^{[1
]}

Lee, Y. M. ^{[1
]}

Lee, G. H. ^{[1
]}

Tan, P. S. ^{[1
]}

Tan, C. Y. ^{[1
]}

Lee, Y. W. C. ^{[1
]}

Tay, Y. L. A. ^{[1
]}

Chan, E. ^{[7
]}

Lim, S. G. ^{[1
]}

机构：

[1] Natl Univ Hlth Syst Singapore, Singapore, Singapore

[2] Abbott Diagnost, Chicago, IL USA

[3] Tan Tock Seng Hosp Singapore, Singapore, Singapore

[4] Singapore Gen Hosp, Singapore, Singapore

[5] Changi Gen Hosp Singapore, Singapore, Singapore

[6] Khoo Teck Puat Hosp Singapore, Singapore, Singapore

[7] Singapore Clin Res Inst, Singapore, Singapore

来源：

关键词：

D O I：

10.1016/S0168-8278(18)31262-5

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI-322

引用

页码：S507 / S508

页数：2